Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALIROCUMAB for Type iia hyperlipidaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 1,913 adverse event reports in the FDA FAERS database where ALIROCUMAB was used for Type iia hyperlipidaemia.

Most Reported Side Effects for ALIROCUMAB

Side Effect Reports % Deaths Hosp.
Myalgia 1,571 6.9% 1 79
Product dose omission 1,354 5.9% 1 63
Injection site pain 1,220 5.3% 4 34
Muscle spasms 1,113 4.9% 2 35
Arthralgia 993 4.3% 3 50
Fatigue 922 4.0% 6 69
Pain 892 3.9% 2 76
Pain in extremity 888 3.9% 1 58
Product dose omission issue 864 3.8% 0 30
Injection site bruising 821 3.6% 2 26
Device issue 785 3.4% 0 23
Influenza like illness 778 3.4% 0 23
Diarrhoea 738 3.2% 1 82
Headache 718 3.1% 1 61
Injection site erythema 679 3.0% 0 25

Other Indications for ALIROCUMAB

Hypercholesterolaemia (4,924) Hyperlipidaemia (3,317) Blood cholesterol increased (2,246) Product used for unknown indication (1,704) Blood cholesterol (1,299) Type v hyperlipidaemia (902) Arteriosclerosis (417) Blood cholesterol abnormal (345) Low density lipoprotein increased (326) Arteriosclerosis coronary artery (145)

Other Drugs Used for Type iia hyperlipidaemia

EVOLOCUMAB (5,556) LOMITAPIDE (3,314) ATORVASTATIN (637) EZETIMIBE (562) ROSUVASTATIN (547) INCLISIRAN (313) SIMVASTATIN (294) PRAVASTATIN (152) JUXTAPID (145) MIPOMERSEN (138)

Related Pages

ALIROCUMAB Full Profile All Type iia hyperlipidaemia Drugs ALIROCUMAB Demographics ALIROCUMAB Timeline